SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:lnu-116295"
 

Search: id:"swepub:oai:DiVA.org:lnu-116295" > Heme Interferes Wit...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Heme Interferes With Complement Factor I-Dependent Regulation by Enhancing Alternative Pathway Activation

Gerogianni, Alexandra (author)
Linnéuniversitetet,Institutionen för kemi och biomedicin (KOB),Linnaeus Ctr Biomat Chem, BMC,Linnaeus Univ, Linnaeus Ctr Biomat Chem, Kalmar, Sweden.;Linnaeus Univ, Dept Chem & Biomed, Kalmar, Sweden
Dimitrov, Jordan D. (author)
Sorbonne Univ, Univ Paris, Ctr Rech Cordeliers, INSERM, Paris, France
Zarantonello, Alessandra (author)
Sorbonne Univ, Univ Paris, Ctr Rech Cordeliers, INSERM, Paris, France
show more...
Poillerat, Victoria (author)
Sorbonne Univ, Univ Paris, Ctr Rech Cordeliers, INSERM, Paris, France
Chonat, Satheesh (author)
Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA.;Emory Univ, Dept Pediat, Sch Med, Atlanta, GA USA
Sandholm, Kerstin (author)
Linnéuniversitetet,Institutionen för kemi och biomedicin (KOB),Linnaeus Univ, Dept Chem & Biomed, Kalmar, Sweden
McAdam, Karin E. (author)
Oslo Univ Hosp, Dept Immunol, Oslo, Norway.;Univ Oslo, Oslo, Norway
Nilsson Ekdahl, Kristina (author)
Uppsala universitet,Linnéuniversitetet,Institutionen för kemi och biomedicin (KOB),Uppsala University, Sweden,Linnaeus Ctr Biomat Chem, BMC,Klinisk immunologi,Linnaeus Univ, Linnaeus Ctr Biomat Chem, Kalmar, Sweden.;Linnaeus Univ, Dept Chem & Biomed, Kalmar, Sweden
Mollnes, Tom E. (author)
Oslo Univ Hosp, Dept Immunol, Oslo, Norway.;Univ Oslo, Oslo, Norway.;Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Trondheim, Norway.;Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway.;Nordland Hosp, Res Lab, Bodo, Norway
Mohlin, Camilla, 1972- (author)
Linnéuniversitetet,Institutionen för kemi och biomedicin (KOB),Linnaeus Ctr Biomat Chem, BMC,Linnaeus Univ, Linnaeus Ctr Biomat Chem, Kalmar, Sweden.;Linnaeus Univ, Dept Chem & Biomed, Kalmar, Sweden
Roumenina, Lubka T. (author)
Sorbonne Univ, Univ Paris, Ctr Rech Cordeliers, INSERM, Paris, France
Nilsson, Per H., 1980- (author)
Linnéuniversitetet,Institutionen för kemi och biomedicin (KOB),Avancerade material,Linnaeus Univ, Linnaeus Ctr Biomat Chem, Kalmar, Sweden.;Linnaeus Univ, Dept Chem & Biomed, Kalmar, Sweden.;Oslo Univ Hosp, Dept Immunol, Oslo, Norway.;Univ Oslo, Oslo, Norway,Linnaeus Ctr Biomat Chem, BMC;HoRB
show less...
 (creator_code:org_t)
2022-07-22
2022
English.
In: Frontiers in Immunology. - : Frontiers Media S.A.. - 1664-3224. ; 13
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Hemolysis, as a result of disease or exposure to biomaterials, is characterized by excess amounts of cell-free heme intravascularly and consumption of the protective heme-scavenger proteins in plasma. The liberation of heme has been linked to the activation of inflammatory systems, including the complement system, through alternative pathway activation. Here, we investigated the impact of heme on the regulatory function of the complement system. Heme dose-dependently inhibited factor I-mediated degradation of soluble and surface-bound C3b, when incubated in plasma or buffer with complement regulatory proteins. Inhibition occurred with factor H and soluble complement receptor 1 as co-factors, and the mechanism was linked to the direct heme-interaction with factor I. The heme-scavenger protein hemopexin was the main contaminant in purified factor I preparations. This led us to identify that hemopexin formed a complex with factor I in normal human plasma. These complexes were significantly reduced during acute vasoocclusive pain crisis in patients with sickle cell disease, but the complexes were normalized at their baseline outpatient clinic visit. Hemopexin exposed a protective function of factor I activity in vitro, but only when it was present before the addition of heme. In conclusion, we present a mechanistic explanation of how heme promotes uncontrolled complement alternative pathway amplification by interfering with the regulatory capacity of factor I. Reduced levels of hemopexin and hemopexin-factor I complexes during an acute hemolytic crisis is a risk factor for heme-mediated factor I inhibition.

Subject headings

NATURVETENSKAP  -- Biologi -- Immunologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Immunology (hsv//eng)
NATURVETENSKAP  -- Biologi -- Mikrobiologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Microbiology (hsv//eng)

Keyword

heme
complement
factor I
co-factor activity
hemopexin
hemolysis
Immunologi
Immunology

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view